MONUMENT ADVOCACY

Lobbying for NOVARTIS · Vaccine and diagnostic manufacturing

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · District of Columbia · House · Senate · $60,000.00 income · posted Apr 20, 2026

Lobbying activity 3

Health Issues

Issues related to domestic healthcare and pricing; Issues related to cell, gene therapies, and radioligand therapies; Issues related to supply chain management, issues related to intellectual property; issues related to tariffs; issues related to ESRD; Most Favored Nation drug pricing policy

Trade (domestic/foreign)

Issues related to ongoing trade negotiations; Issues related to US/China relations; Issues related to international intellectual property; Issues related to global health; issues related to supply chain; and issues related to tariffs, issues related to ESRD.

Taxation/Internal Revenue Code

Issues related to US and international tax provisions; issues related to ESRD

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.